Microphthalmia with limb anomalies

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1106OMIM:206920Q87.2
Who is this for?
Show terms as
19Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Microphthalmia with limb anomalies, also known as ophthalmoacromelic syndrome or Waardenburg anophthalmia syndrome, is an extremely rare congenital disorder characterized by the combination of severe eye malformations and limb defects. The condition is caused by mutations in the SMOC1 gene, which plays an important role in embryonic development of the eyes and limbs. Affected individuals typically present at birth with bilateral anophthalmia (absence of the eyes) or severe microphthalmia (abnormally small eyes), along with various limb anomalies including syndactyly (fusion of fingers or toes), oligodactyly (fewer than normal digits), and synostosis (abnormal fusion of bones). Additional features may include fibular and tibial defects, as well as other skeletal abnormalities. The condition primarily affects the ocular and musculoskeletal systems. Eye involvement ranges from complete absence of the eyeball to severely reduced eye size, resulting in significant visual impairment or blindness. Limb anomalies can vary in severity and may involve both upper and lower extremities. Some patients may also have additional findings such as intellectual disability or craniofacial anomalies, though these are less consistently reported. The disorder is present from birth and is typically recognized in the neonatal period based on the striking combination of eye and limb findings. There is currently no cure for microphthalmia with limb anomalies. Treatment is supportive and multidisciplinary, involving ophthalmologists for management of eye socket development (including conformers or prosthetic eyes for cosmetic purposes), orthopedic specialists for limb anomalies, and rehabilitation services. Surgical interventions may be considered for specific skeletal malformations. Genetic counseling is recommended for affected families. Early intervention programs addressing visual impairment and any developmental delays are important components of care.

Also known as:

Clinical phenotype terms— hover any for plain English:

Finger aplasiaHP:0009380True anophthalmiaHP:0011478Synostosis of jointsHP:0100240
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events
Dec 2026Efficacy of Autologous Adipose Derived Stromal Vascular Fraction for Musculoskeletal Conditions

Dubai Health Authority — NA

TrialNOT YET RECRUITING
May 2026Image Guided Genicular Nerve Radiofrequency Ablation for Chronic Knee Osteoarthritis

Aga Khan University — NA

TrialNOT YET RECRUITING
Apr 2026Diaphragm-Sparing Regional Anesthesia Techniques for Shoulder Surgery

Poznan University of Medical Sciences — NA

TrialNOT YET RECRUITING
Mar 2026Arthrosemid vs. Steroid for the Management Knee Osteoarthritis

Cappagh National Orthopaedic Hospital — PHASE4

TrialRECRUITING
Feb 2026Pyrocarbon Hemiarthroplasty Versus Total Shoulder Arthroplasty for the Treatment of Glenohumeral Osteoarthritis

Washington University School of Medicine — NA

TrialENROLLING BY INVITATION
Jan 2026Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA

Poznan University of Medical Sciences — NA

TrialRECRUITING
Jan 2026Partial vs Total Knee Replacement for Medial Knee Osteoarthritis: a Prospective Randomized Controlled Study

Medical University of Graz — NA

TrialNOT YET RECRUITING
Dec 2025Phase 4 Study of Laybon Tab. in Knee Osteoarthritis

Mather's Pharm. Co., Ltd. — PHASE4

TrialNOT YET RECRUITING
Dec 2025Perioperative Colchicine for TKA

Geisinger Clinic — PHASE4

TrialNOT YET RECRUITING
Nov 2025Corticosteroid Against Saline Injections for Thumb Osteoarthritis (CASITOA)

Université du Québec à Trois-Rivières — PHASE2

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Microphthalmia with limb anomalies.

View clinical trials →

No actively recruiting trials found for Microphthalmia with limb anomalies at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Microphthalmia with limb anomalies community →

Specialists

19 foundView all specialists →
KF
Kyoko Fukahori
PITTSBURGH, PA
Specialist
1 Microphthalmia with limb anomalies publication
YY
Yoshiro Yoshikawa
Specialist
1 Microphthalmia with limb anomalies publication
KN
Keisuke Nagasaki
Specialist
1 Microphthalmia with limb anomalies publication
HS
Hirotomo Saitsu
Specialist
1 Microphthalmia with limb anomalies publication
KY
Kaori Yamoto
Specialist
1 Microphthalmia with limb anomalies publication
MM
Michael A Mont, MD
BALTIMORE, MD
Specialist
PI on 2 active trials
YM
Yusuf Yazici, M.D.
NEW YORK, NY
Specialist
PI on 6 active trials
CY
Chikashi Yamakawa
Specialist
1 Microphthalmia with limb anomalies publication
KN
Kotaro Nishida
Specialist
1 Microphthalmia with limb anomalies publication
TS
Takanao Shimabukuro
Specialist
1 Microphthalmia with limb anomalies publication
RK
Ryo Katsuki
Specialist
1 Microphthalmia with limb anomalies publication
YT
Yasunori Tome
Specialist
1 Microphthalmia with limb anomalies publication
SF
Shogo Fukase
Specialist
1 Microphthalmia with limb anomalies publication
HK
Hideo Kinjo
Specialist
1 Microphthalmia with limb anomalies publication
HO
Hiromichi Oshiro
Specialist
1 Microphthalmia with limb anomalies publication
AM
Antonella Fioravanti, MD
Specialist
PI on 2 active trials1 Microphthalmia with limb anomalies publication
BD
Brennan Boettcher, D.O
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Microphthalmia with limb anomalies.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Microphthalmia with limb anomaliesForum →

No community posts yet. Be the first to share your experience with Microphthalmia with limb anomalies.

Start the conversation →

Latest news about Microphthalmia with limb anomalies

Disease timeline:

New recruiting trial: Precision Rehabilitation: Mechanisms and Efficacy of Vibration in Exercise Training for Degenerative Knee Osteoarthritis

A new clinical trial is recruiting patients for Microphthalmia with limb anomalies

New recruiting trial: The Effect of Balance Training Using a Dynamometric Platform in Patients Undergoing Total Knee Arthroplasty

A new clinical trial is recruiting patients for Microphthalmia with limb anomalies

New recruiting trial: Effect of Anti-inflammatory (ITIS) Diet in Knee Osteoarthritis

A new clinical trial is recruiting patients for Microphthalmia with limb anomalies

New recruiting trial: Use of Leukocyte-Rich PRP or Leukocyte-Free PRP in the Treatment of Hip Osteoarthritis

A new clinical trial is recruiting patients for Microphthalmia with limb anomalies

New recruiting trial: Amniotic Suspension Allograft Injection for Knee Osteoarthritis

A new clinical trial is recruiting patients for Microphthalmia with limb anomalies

New recruiting trial: Non-weight Bearing in Hip Joint With Accompanying Joint Pain Might Not Progress Radiographic OA

A new clinical trial is recruiting patients for Microphthalmia with limb anomalies

New recruiting trial: Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Shoulder

A new clinical trial is recruiting patients for Microphthalmia with limb anomalies

New recruiting trial: Mobilizing Hispanics With Knee Osteoarthritis

A new clinical trial is recruiting patients for Microphthalmia with limb anomalies

New recruiting trial: COntralateral CorticoSTeroid Injection in Total Knee Arthroplasty

A new clinical trial is recruiting patients for Microphthalmia with limb anomalies

New recruiting trial: Acupuncture vs Sham Acupuncture for Hand Osteoarthritis

A new clinical trial is recruiting patients for Microphthalmia with limb anomalies

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Microphthalmia with limb anomalies

What is Microphthalmia with limb anomalies?

Microphthalmia with limb anomalies, also known as ophthalmoacromelic syndrome or Waardenburg anophthalmia syndrome, is an extremely rare congenital disorder characterized by the combination of severe eye malformations and limb defects. The condition is caused by mutations in the SMOC1 gene, which plays an important role in embryonic development of the eyes and limbs. Affected individuals typically present at birth with bilateral anophthalmia (absence of the eyes) or severe microphthalmia (abnormally small eyes), along with various limb anomalies including syndactyly (fusion of fingers or toes)

How is Microphthalmia with limb anomalies inherited?

Microphthalmia with limb anomalies follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Microphthalmia with limb anomalies typically begin?

Typical onset of Microphthalmia with limb anomalies is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Microphthalmia with limb anomalies?

19 specialists and care centers treating Microphthalmia with limb anomalies are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.